576
|
Chen X, Yang D, Li L, Li Y, Zhang Q, Wang W. Early endocrine, metabolic characteristics of polycystic ovary syndrome (PCOS): comparison between lean and overweight adolescents in Southern-China. Fertil Steril 2008. [DOI: 10.1016/j.fertnstert.2008.07.199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
577
|
Yang D, Huang H, Mo Y, Zhang Q, Wang W, Li Y. Effects of GnRH agonist on the sensitivity to 5-FU and epirubicin and ERα,MDR1 and mRNA expression of human breast cancer cell lines. Fertil Steril 2008. [DOI: 10.1016/j.fertnstert.2008.07.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
578
|
Blumberg PM, Kedei N, Lewin NE, Yang D, Czifra G, Pu Y, Peach ML, Marquez VE. Wealth of opportunity - the C1 domain as a target for drug development. Curr Drug Targets 2008; 9:641-52. [PMID: 18691011 PMCID: PMC3420355 DOI: 10.2174/138945008785132376] [Citation(s) in RCA: 71] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The diacylglycerol-responsive C1 domains of protein kinase C and of the related classes of signaling proteins represent highly attractive targets for drug development. The signaling functions that are regulated by C1 domains are central to cellular control, thereby impacting many pathological conditions. Our understanding of the diacylglycerol signaling pathways provides great confidence in the utility of intervention in these pathways for treatment of cancer and other conditions. Multiple compounds directed at these signaling proteins, including compounds directed at the C1 domains, are currently in clinical trials, providing strong validation for these targets. Extensive understanding of the structure and function of C1 domains, coupled with detailed insights into the molecular details of ligand - C1 domain interactions, provides a solid basis for rational and semi-rational drug design. Finally, the complexity of the factors contributing to ligand - C1 domain interactions affords abundant opportunities for manipulation of selectivity; indeed, substantially selective compounds have already been identified.
Collapse
|
579
|
Watanabe Y, Wei Q, Yang D, Chen X, Du H, Yang J, Sato K, Naito Y, Miyazaki N. Swimming behavior in relation to buoyancy in an open swimbladder fish, the Chinese sturgeon. J Zool (1987) 2008. [DOI: 10.1111/j.1469-7998.2008.00451.x] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
580
|
Zhou C, Wu G, Feng Y, Li Q, Su H, Mais DE, Zhu Y, Li N, Deng Y, Yang D, Wang MW. Discovery and biological characterization of a novel series of androgen receptor modulators. Br J Pharmacol 2008. [DOI: 10.1038/bjp.2008.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
581
|
Lurje G, Zhang W, Schultheis AM, Yang D, Groshen S, Hendifar AE, Husain H, Gordon MA, Nagashima F, Chang HM, Lenz HJ. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 2008; 19:1734-41. [PMID: 18550579 DOI: 10.1093/annonc/mdn368] [Citation(s) in RCA: 103] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Identifying molecular markers for tumor recurrence is critical in successfully selecting patients with stage III colon cancer who are more likely to benefit from adjuvant chemotherapy. The present study analyzed a subset of 10 polymorphisms within eight genes involved in the tumor angiogenesis pathway and their impact on prognosis in stage III colon cancer patients treated with adjuvant chemotherapy. PATIENTS AND METHODS Blood samples were obtained from 125 patients with locally advanced colon cancer at University of Southern California medical facilities. DNA was extracted from peripheral blood and the genotypes were analyzed using PCR-restriction fragment length polymorphism and 5'-end [gamma-(33)P] ATP-labeled PCR protocols. RESULTS Polymorphisms in vascular endothelial growth factor (VEGF) (C+936T; P = 0.003, log-rank test) and interleukin-8 (IL-8) (T-251A; P = 0.04, log-rank test) were independently associated with risk of recurrence in stage III colon cancer patients. In combined analysis, grouping alleles into favorable versus nonfavorable alleles, high expression variants of VEGF C+936T and IL-8 T-251A were associated with a higher likelihood of developing tumor recurrence (P < 0.001). CONCLUSION High expression variants of VEGF C+936T and IL-8 T-251A were associated with shorter time to tumor recurrence, indicating that the analysis of angiogenesis-related gene polymorphisms may help to identify patient subgroups at high risk for tumor recurrence.
Collapse
|
582
|
Zhao T, Bradley J, Noel C, Yalavarthy P, Parikh P, Yang T, Yang D, Mutic S, Low D. MO-E-AUD C-06: Application of 5D Breathing Motion Model for Monitoring Radiation Damage. Med Phys 2008. [DOI: 10.1118/1.2962395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
583
|
Yang D, Lu W, Low D, Deasy J, El Naqa I. WE-C-351-04: 4DCT Motion Estimation and Modeling. Med Phys 2008. [DOI: 10.1118/1.2962711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
584
|
ElNaqa I, Nofal A, Trovo M, Apte A, Yang D, Bradley J, Deasy J, Low D. SU-DD-A4-02: Assessment of PET Estimated Tumor Volume by Four-Dimensional Computed Tomography Measurements. Med Phys 2008. [DOI: 10.1118/1.2961369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
585
|
ElNaqa I, Apte A, Yang D, Noel C, Bradle J, Deasy J. WE-E-AUD C-07: A Robust Approach for Estimating Tumor Volume Change During Radiotherapy of Lung Cancer. Med Phys 2008. [DOI: 10.1118/1.2962788] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
586
|
Li H, Thorstad W, Zhu J, Wu B, Yang D, Low D, Lu W. SU-GG-I-99: Validation and Comparison of 3D Image Registration Approaches for Adaptive IMRT in Head-And-Neck Cancer. Med Phys 2008. [DOI: 10.1118/1.2961497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
587
|
Yang D, Apte A, Santanam L, El Naqa I, Deasy J. WE-E-AUD A-06: Image and Dose Processing for Image Guided Adaptive Radiation Therapy and Outcome Research. Med Phys 2008. [DOI: 10.1118/1.2962773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
588
|
Silver E, Parikh P, Yang D, Smith R, Low D. SU-GG-J-96: Fiducial Placement Guidelines for Thoracic Radiation Therapy Determined by 4DCT. Med Phys 2008. [DOI: 10.1118/1.2961646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
589
|
Husain H, Lurje G, Yang D, Zhang W, Hendifar AE, Ashouri S, Pohl A, Manegold PC, Iqbal S, El- Khoueiry AB, Lenz HJ. Ethnicity is associated with recurrence in patients with resected gastric cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.15511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
590
|
Hendifar AE, Lurje G, Lenz F, Pohl A, Manegold PC, Togawa K, Husain H, Lenz HJ, Yang D. Sex, age, and ethnicity are associated with survival in metastatic colorectal cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.4015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
591
|
Kang Y, Chang H, Zang D, Lee J, Kim T, Yang D, Jang S, Yook J, Oh S, Kim B. Postoperative adjuvant chemotherapy for grossly serosa-positive advanced gastric cancer: A randomized phase III trial of intraperitoneal cisplatin and early mitomycin-C plus long-term doxifluridine plus cisplatin (iceMFP) versus mitomycin-C plus short- term doxifluridine (Mf) (AMC 0101) (NCT00296322). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.lba4511] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
592
|
Yang D, Lenz C, Togawa K, Lurje G, Pohl A, Manegold PC, Ning Y, Groshen SG, Lenz HJ. Age and ethnicity predict overall survival in patients with metastatic gastric cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.15500] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
593
|
Manegold PC, El-Khoueiry AB, Lurje G, Singh H, Yang D, Zhang W, Chang H, Shriki J, Pohl A, Iqbal S, Lenz HJ. ICAM-1, GRP-78, and NFkB gene polymorphisms and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with first line 5-FU or capecitabine in combination with oxaliplatin and bevacizumab (FOLFOX/BV or XELOX/BV). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.4134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
594
|
Lurje G, Husain H, Hendifar AE, Zhang W, Yang D, Pohl A, Manegold PC, Ning Y, Iqbal S, El- Khoueiry AB, Lenz HJ. Use of thrombin-receptor 1 (PAR-1), endostatin (ES), and interleukin-8 (IL-8) gene polymorphisms to predict tumor recurrence in patients with surgically resected gastric cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.4559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
595
|
Wilson PM, Yang D, Shi MM, Zhang W, Jacques C, Barrett JC, Daneneberg K, Trarbach T, Folprecht G, Meinhardt G, Lenz HJ. Use of intratumoral mRNA expression of genes involved in angiogenesis and HIF1 pathway to predict outcome to VEGFR tyrosine kinase inhibitor (TKI) in patients enrolled in CONFIRM1 and CONFIRM2. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.4002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
596
|
Pohl A, Lurje G, Zhang W, Yang D, Hendifar AE, Manegold PC, Ning Y, Iqbal S, El-Khoueiry AB, Lenz HJ. Use of polymorphisms in interleukin-1β (IL-1β) and IL-1 receptor antagonist (IL-1Ra) to predict tumor recurrence in stage II colon cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.4138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
597
|
Chang H, Kang Y, Min Y, Zang D, Kim G, Yang D, Jang S, Yook J, Oh S, Kim B. A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (AMC 0201) (NCT00296335). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.4531] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
598
|
Iqbal S, Lenz HJ, Yang D, Ramanathan RK, Bahary N, Shibata S, Morgan RJ, Gandara DR. A randomized phase II study of BAY 43–9006 in combination with gemcitabine in metastatic pancreatic carcinoma: A California Cancer Consortium study (CCC-P). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.11082] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
599
|
Lenz HJ, Zhang W, Shi MM, Jacques C, Barrett JC, Danenberg KD, Hoffmann AC, Trarbach T, Folprecht G, Meinhardt G, Yang D. ERCC-1 gene expression levels and outcome to FOLFOX chemotherapy in patients enrolled in CONFIRM1 and CONFIRM2. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.4131] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
600
|
Marchant D, Si X, Luo H, McManus B, Yang D. The impact of CVB3 infection on host cell biology. Curr Top Microbiol Immunol 2008; 323:177-98. [PMID: 18357770 DOI: 10.1007/978-3-540-75546-3_8] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
Abstract
CVB3 myocarditis can lead to dilated cardiomyopath (DCM). DCM is one of the leading causes of the need for heart transplantation, so it is important to understand the life cycle of CVB3 and its interactions with the host cell. Infection causes rapid death of host cardiomyocytes by altering normal cellular homeostasis for the efficient release of progeny virion. In this chapter, we will examine the impact that CVB3 replication has on host cell biology, from events that take place at receptor ligation to progeny virus release. The primary focus will be on the myriad of signalling pathways that are activated at all stages of virus replication and their downstream effects. We will also discuss some of the extracellular effects of infection as well as immune and matrixmetalloprotease activation. Interactions of host cell proteins with the 5' untranslated region (UTR) are required for translation and replication of CVB3. These interactions do not always benefit the virus since the interactions of a 28-kDa host protein with the 5' UTR are thought to be responsible for inhibitory activity against CVB3. Finally, we will discuss how the elucidation of the different stages of replication has provided the opportunity to develop novel strategies for combating CVB3 infection.
Collapse
|